NCT06710093View on ClinicalTrials.gov

Power of Liquid Biopsy Tracking in Immunotherapy Treated Stage IV Melanoma

Not yet recruitingOBSERVATIONAL
Enrollment

100

Participants

Timeline

Start Date

February 1, 2025

Primary Completion Date

January 1, 2028

Study Completion Date

January 1, 2029

Conditions
Metastatic Melanoma
Trial Locations (1)

SW3 6JJ

The Royal Marsden, Chelsea

All Listed Sponsors
lead

Royal Marsden NHS Foundation Trust

OTHER

NCT06710093 - Power of Liquid Biopsy Tracking in Immunotherapy Treated Stage IV Melanoma | Biotech Hunter | Biotech Hunter